BMJ Group: GLP-1 Diabetes Drugs Linked to Increased Risk of Hair Loss
July 25, 2026
July 25, 2026
LONDON, England, July 25 (TNSjou) -- BMJ Group issued the following news release about The BMJ:
* * *
GLP-1 diabetes drugs linked to increased risk of hair loss
Absolute risk low, but findings may help inform treatment decisions, say researchers
-
Use of glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity are associated with an increased risk of hair loss (alopecia) in adults with type 2 dia . . .
* * *
GLP-1 diabetes drugs linked to increased risk of hair loss
Absolute risk low, but findings may help inform treatment decisions, say researchers
-
Use of glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity are associated with an increased risk of hair loss (alopecia) in adults with type 2 dia . . .